User profiles for Anju Nohria

Anju Nohria

Brigham and Women's Hospital
Verified email at partners.org
Cited by 12133

Cardiorenal interactions: insights from the ESCAPE trial

A Nohria, V Hasselblad, A Stebbins, DF Pauly… - Journal of the American …, 2008 - jacc.org
Objectives : We examined the ESCAPE (Evaluation Study of Congestive Heart Failure and
Pulmonary Artery Catheterization Effectiveness) database to understand the impact and …

Role of nitric oxide in the regulation of digital pulse volume amplitude in humans

A Nohria, M Gerhard-Herman… - Journal of applied …, 2006 - journals.physiology.org
Measurement of the increase in digital pulse volume amplitude (PVA) during reactive hyperemia
relative to baseline (PVA-RH) is being applied widely as a convenient test of nitric oxide …

Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure

A Nohria, SW Tsang, JC Fang, EF Lewis… - Journal of the American …, 2003 - jacc.org
Objectives : This study was designed to determine the relevance of a proposed classification
for advanced heart failure (HF). Profiles based on clinical assessment of congestion and …

Myocarditis in patients treated with immune checkpoint inhibitors

SS Mahmood, MG Fradley, JV Cohen, A Nohria… - Journal of the American …, 2018 - jacc.org
Nohria has received research support from Amgen; and has been a consultant for Takeda
Oncology. Dr. Heinzerling has received consultancy, advisory board, and speaker fees from …

Medical management of advanced heart failure

A Nohria, E Lewis, LW Stevenson - Jama, 2002 - jamanetwork.com
ContextAdvanced heart failure, defined as persistence of limiting symptoms despite therapy
with agents of proven efficacy, accounts for the majority of morbidity and mortality in heart …

Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease

A Nohria, ME Grunert, Y Rikitake, K Noma… - Circulation …, 2006 - Am Heart Assoc
Investigations from basic biology suggest that activation of the Rho/Rho kinase pathway
reduces the bioavailability of nitric oxide (NO) and thereby promotes atherosclerosis and its …

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

…, NN Lang, JE Liu, TG Neilan, A Nohria… - European heart …, 2022 - academic.oup.com
The discipline of Cardio-Oncology has seen tremendous growth over the past decade. It is
devoted to the cardiovascular (CV) care of the cancer patient, especially to the mitigation and …

Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19

…, GD Demetri, A Giordano, K Kelleher, A Nohria… - JAMA …, 2021 - jamanetwork.com
Importance COVID-19 is a life-threatening illness for many patients. Prior studies have
established hematologic cancers as a risk factor associated with particularly poor outcomes from …

Cancer therapy–related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging

…, CE Hamo, D Cardinale, B Ky, A Nohria… - Circulation: Heart …, 2016 - Am Heart Assoc
Advances in cancer therapy have resulted in significant improvement in long-term survival
for many types of cancer but have also resulted in untoward side effects associated with …

Statins inhibit Rho kinase activity in patients with atherosclerosis

A Nohria, A Prsic, PY Liu, R Okamoto, MA Creager… - Atherosclerosis, 2009 - Elsevier
BACKGROUND: In addition to inhibiting cholesterol synthesis, statins (HMG-CoA reductase
inhibitors) decrease the formation of isoprenoid intermediates required for the activation of …